Find Federal Grants
U.S. Mission to India · H-NOFO-22-100
U.S. Mission to India · H-NOFO-22-101
Health Resources and Services Administration · HRSA-22-124
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-162
National Institutes of Health · RFA-RM-22-018
Limited Interaction Targeted Epidemiology: Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · RFA-AI-22-024
Health Resources and Services Administration · HRSA-22-149
National Institutes of Health · RFA-DK-22-011
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
National Institutes of Health · PAR-22-131
Department of Homeland Security - FEMA · DHS-22-TTP-132-00-01
National Institutes of Health · PAR-22-150
NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required)
National Institutes of Health · PAR-22-149
Substance Abuse and Mental Health Services Adminis · SP-22-004
Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-23-016
Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required)
National Institutes of Health · RFA-MD-22-009
Denali Commission Program Grants
Denali Commission · DC-WP-22-001
Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)
National Institutes of Health · RFA-RM-22-016
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
National Institutes of Health · PAR-22-136
Somatic Cell Genome Editing Program Translational Coordination and Dissemination Center (TCDC) (U24 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-RM-22-017
IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)
National Institutes of Health · RFA-RM-22-015